048530.KQ
iNtRON Biotechnology, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,810.00
+0.00%Margins
Gross margin
34.4%
EBITDA margin
-119.8%
EBIT margin
-109.2%
Net margin
-146.8%
FCF margin
-90.0%
-17.1%
Return on equity
-15.6%
Return on assets
-11.8%
Return on invested capital
0.10x
Asset turnover
-KRW 5.0B
Cash from operations
KRW 1.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026